| Obesity, weight loss and prognosis in type 2 diabetes MEJ Lean, JK Powrie, AS Anderson, PH Garthwaite Diabetic medicine 7 (3), 228-233, 1990 | 472 | 1990 |
| Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis S Coster, MC Gulliford, PT Seed, JK Powrie, R Swaminathan Diabetic Medicine 17 (11), 755-761, 2000 | 282 | 2000 |
| Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death S Arif, F Moore, K Marks, T Bouckenooghe, CM Dayan, R Planas, ... Diabetes 60 (8), 2112-2119, 2011 | 272 | 2011 |
| Monitoring blood glucose control in diabetes mellitus: a systematic review S Coster, MC Gulliford, PT Seed, JK Powrie, R Swaminathan Health Technology Assessment 4 (12), 1, 2000 | 258 | 2000 |
| Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes S Arif, P Leete, V Nguyen, K Marks, NM Nor, M Estorninho, ... Diabetes 63 (11), 3835-3845, 2014 | 246 | 2014 |
| Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes M Alhadj Ali, YF Liu, S Arif, D Tatovic, H Shariff, VB Gibson, N Yusuf, ... Science translational medicine 9 (402), eaaf7779, 2017 | 208 | 2017 |
| Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study S Longobardi, N Keay, C Ehrnborg, A Cittadini, T Rosen, R Dall, ... The Journal of Clinical Endocrinology & Metabolism 85 (4), 1505-1512, 2000 | 186 | 2000 |
| Detection of growth hormone abuse in sport JK Powrie, EE Bassett, T Rosen, JO Jørgensen, R Napoli, L Sacca, ... Growth Hormone & IGF Research 17 (3), 220-226, 2007 | 161 | 2007 |
| The influence of the route of oestrogen administration on serum levels of cortisol‐binding globulin and total cortisol AC Qureshi, A Bahri, LA Breen, SC Barnes, JK Powrie, SM Thomas, ... Clinical endocrinology 66 (5), 632-635, 2007 | 154 | 2007 |
| β-Cell–specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure A Skowera, K Ladell, JE McLaren, G Dolton, KK Matthews, E Gostick, ... Diabetes 64 (3), 916-925, 2015 | 143 | 2015 |
| Circulating preproinsulin signal peptide–specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells D Kronenberg, RR Knight, M Estorninho, RJ Ellis, MG Kester, A De Ru, ... Diabetes 61 (7), 1752-1759, 2012 | 124 | 2012 |
| Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes JK Powrie, GF Watts, JN Ingham, NA Taub, PJ Talmud, KM Shaw Bmj 309 (6969), 1608-1612, 1994 | 95 | 1994 |
| The prevalence and natural history of pituitary hemorrhage in prolactinoma KN Sarwar, MSB Huda, V Van de Velde, L Hopkins, S Luck, R Preston, ... The Journal of Clinical Endocrinology & Metabolism 98 (6), 2362-2367, 2013 | 87 | 2013 |
| Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH AT Kicman, JP Miell, JD Teale, J Powrie, PJ Wood, P Laidler, PJ Milligan, ... Clinical Endocrinology 47 (1), 43-50, 1997 | 83 | 1997 |
| Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature JK Powrie, Y Powell, AB Ayers, C Lowy, PH Sönksen Clinical endocrinology 42 (3), 315-322, 1995 | 83 | 1995 |
| 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH‐secreting neuroendocrine tumours J Kumar, M Spring, PV Carroll, SF Barrington, JK Powrie Clinical endocrinology 64 (4), 371-374, 2006 | 66 | 2006 |
| Apolipoprotein B independently predicts progression of very—low-level albuminuria in insulin-dependent diabetes mellitus GF Watts, JK Powrie, SF O'brien, KM Shaw Metabolism 45 (9), 1101-1107, 1996 | 54 | 1996 |
| Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults MG Giannoulis, MA Boroujerdi, J Powrie, R Dall, R Napoli, C Ehrnborg, ... Clinical Endocrinology 62 (3), 315-322, 2005 | 53 | 2005 |
| Growth Hormone Replacement Therapy for Growth Hormone—Deficient Adults JK Powrie, A Weissberger, P Sönksen Drugs 49 (5), 656-663, 1995 | 53 | 1995 |
| Factors determining the remission of microprolactinomas after dopamine agonist withdrawal MSB Huda, NB Athauda, MM Teh, PV Carroll, JK Powrie Clinical endocrinology 72 (4), 507-511, 2010 | 43 | 2010 |
